Inside Precision Medicine January 23, 2026
Better information—molecular or not—for clinical decisions is the key to precision medicine, explains the venture capital founder and managing director
Jenny Rooke, PhD, started the investment company Genoa Ventures out of frustration. As a geneticist, she saw firsthand how the tools powering life sciences and healthcare lag far behind the complexity of real biology. After stints in industry and investing, Rooke launched the venture capital firm eight years ago to back deeply technical founders building the infrastructure for better biology—tools and platforms that rarely get funded in a world obsessed with therapeutics. Genoa’s core belief is that precision medicine is rooted in informed medicine: integrating molecular, physiological,...
Today's Sponsors
Today's Sponsor